Hengrui Medicine: Publication of H Share Issuance Hearing Information Package

On the morning of May 6th, Hengrui Pharmaceutical announced that, in accordance with the arrangements for the issuance and listing, the company has posted the overseas listed foreign shares issuance and listing hearing materials on the website of the Hong Kong Stock Exchange. The post-hearing materials were published by the company in accordance with the requirements of the Hong Kong Stock Exchange and the Securities and Futures Commission of Hong Kong, for the sole purpose of providing information to the Hong Kong public and eligible investors. At the same time, the post-hearing materials are draft versions, and the information contained in them may be updated and changed as necessary.